These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1905 related articles for article (PubMed ID: 19152397)
1. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy. Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397 [TBL] [Abstract][Full Text] [Related]
2. Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons. Nebbia G; Garcia-Diaz A; Ayliffe U; Smith C; Dervisevic S; Johnson M; Gilson R; Tedder R; Geretti AM J Med Virol; 2007 Oct; 79(10):1464-71. PubMed ID: 17705185 [TBL] [Abstract][Full Text] [Related]
3. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553 [TBL] [Abstract][Full Text] [Related]
4. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India. Gupta S; Singh S BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948 [TBL] [Abstract][Full Text] [Related]
5. [Investigation of occult hepatitis B in HIV infected patients]. Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079 [TBL] [Abstract][Full Text] [Related]
6. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
7. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody. Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
9. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. Lukhwareni A; Burnett RJ; Selabe SG; Mzileni MO; Mphahlele MJ J Med Virol; 2009 Mar; 81(3):406-12. PubMed ID: 19152393 [TBL] [Abstract][Full Text] [Related]
10. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa. Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918 [TBL] [Abstract][Full Text] [Related]
11. [Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]. Smit MC; Haverkamp MH; Weersink AJ; Boucher CA; Hoepelman IM Ned Tijdschr Geneeskd; 2004 Nov; 148(47):2330-4. PubMed ID: 15587052 [TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment]. Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739 [TBL] [Abstract][Full Text] [Related]
14. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ; J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912 [TBL] [Abstract][Full Text] [Related]
15. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B]. Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of occult hepatitis B in Baltimore injection drug users. Torbenson M; Kannangai R; Astemborski J; Strathdee SA; Vlahov D; Thomas DL Hepatology; 2004 Jan; 39(1):51-7. PubMed ID: 14752822 [TBL] [Abstract][Full Text] [Related]
18. Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness. Landrum ML; Roediger MP; Fieberg AM; Weintrob AC; Okulicz JF; Crum-Cianflone NF; Ganesan A; Lalani T; Macalino GE; Chun HM J Med Virol; 2011 Sep; 83(9):1537-43. PubMed ID: 21739443 [TBL] [Abstract][Full Text] [Related]
19. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. Soriano V; Mocroft A; Peters L; Rockstroh J; Antunes F; Kirkby N; de Wit S; Monforte Ad; Flisiak R; Lundgren J; J Antimicrob Chemother; 2010 Mar; 65(3):548-55. PubMed ID: 20051475 [TBL] [Abstract][Full Text] [Related]
20. Occult hepatitis B virus infection in HIV-infected Lebanese patients with isolated antibodies to hepatitis B core antigen. Ramia S; Mokhbat J; Ramlawi F; El-Zaatari M Int J STD AIDS; 2008 Mar; 19(3):197-9. PubMed ID: 18397562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]